[Skin reactions of delayed hypersensitivity in melanoblastoma].
Cell factors of nonspecific immunity were estimated in 99 patients with different stages of melanoblastoma by delayed hypersensitivity skin test to tuberculin and DNCB (2,4-dinitrochlorobenzene). The skin test to DNCB is found to correlate with the clinical manifestations of the disease, while the skin test to tuberculin is not related with the degree of tumor spread. It is considered not rational to use the test concerned to define one of the immune cell factors in patients with melanoblastoma during the tumor progression.